Hinge Health Reports Strong Q4 & Full Year 2025 Results, Initiates Share Repurchase

summarizeSummary

Hinge Health reported record Q4 and full year 2025 financial results with strong revenue growth, significant profitability improvements, robust free cash flow, and initiated a share repurchase program, alongside positive 2026 guidance.

check_boxKey Events

• Record Q4 and Full Year 2025 Financial Results

  Hinge Health reported Q4 2025 revenue of $170.7 million, a 46% increase year-over-year, and full year 2025 revenue of $587.9 million, up 51% from 2024.

• Significant Profitability Improvement

  Non-GAAP income from operations for Q4 2025 surged 124% to $48.0 million, and for the full year 2025, the company achieved non-GAAP income from operations of $119.5 million, a substantial turnaround from a loss in 2024.

• Strong Free Cash Flow Generation

  The company generated $61.5 million in free cash flow in Q4 2025, a 65% increase, and $179.6 million for the full year 2025, representing a 297% increase year-over-year.

• Share Repurchase Program Activity

  Hinge Health repurchased $65.0 million of its Class A common stock during Q4 2025, as part of a $250.0 million program authorized in November 2025.

auto_awesomeAnalysis

Hinge Health, Inc. announced robust financial results for the fourth quarter and full year 2025, demonstrating significant growth and a strong shift towards profitability. The company reported substantial year-over-year revenue increases and a remarkable improvement in non-GAAP operating income, moving from a loss in 2024 to a significant profit in 2025. The strong free cash flow generation and the execution of a share repurchase program underscore the company's financial health and commitment to shareholder returns. The positive guidance for 2026 suggests continued momentum in revenue growth and expanding margins, reinforcing investor confidence in its digital musculoskeletal care leadership.